| Alcoholic liver disease HK Seitz, R Bataller, H Cortez-Pinto, B Gao, A Gual, C Lackner, ... Nature reviews Disease primers 4 (1), 16, 2018 | 1088 | 2018 |
| EASL clinical practical guidelines: management of alcoholic liver disease European Association For The Study Of The Liver Journal of hepatology 57 (2), 399-420, 2012 | 723 | 2012 |
| EASL Clinical Practice Guidelines: Management of alcohol-related liver disease M Thursz, A Gual, C Lackner, P Mathurin, C Moreno, L Spahr, M Sterneck, ... Journal of hepatology 69 (1), 154-181, 2018 | 702 | 2018 |
| Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefene K Mann, A Bladström, L Torup, A Gual, W van den Brink Biological psychiatry 73 (8), 706-713, 2013 | 428 | 2013 |
| Audit-3 and audit-4: effectiveness of two short forms of the alcohol use disorders identification test A Gual, L Segura, M Contel, N Heather, J Colom Alcohol and alcoholism 37 (6), 591-596, 2002 | 403 | 2002 |
| A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence A Gual, Y He, L Torup, W van den Brink, K Mann, ESENSE 2 Study Group European neuropsychopharmacology 23 (11), 1432-1442, 2013 | 320 | 2013 |
| Defining substance use disorders: do we really need more than heavy use? J Rehm, S Marmet, P Anderson, A Gual, L Kraus, DJ Nutt, R Room, ... Alcohol and alcoholism 48 (6), 633-640, 2013 | 297 | 2013 |
| Alcohol y atención primaria de la salud: informaciones clínicas básicas para la identificación y el manejo de riesgos y problemas P Anderson, A Gual, J Colon OPS (Organizacion Panamericana de la Salud), 2008 | 217 | 2008 |
| Prevalence of and potential influencing factors for alcohol dependence in Europe J Rehm, P Anderson, J Barry, P Dimitrov, Z Elekes, F Feijão, U Frick, ... European addiction research 21 (1), 6-18, 2014 | 216 | 2014 |
| Treatment of alcohol use disorders in patients with alcoholic liver disease G Addolorato, A Mirijello, P Barrio, A Gual Journal of hepatology 65 (3), 618-630, 2016 | 214 | 2016 |
| Efficacy of as-needed nalmefene in alcohol-dependent patients with at least a high drinking risk level: results from a subgroup analysis of two randomized controlled 6-month … W van den Brink, HJ Aubin, A Bladström, L Torup, A Gual, K Mann Alcohol and alcoholism 48 (5), 570-578, 2013 | 182 | 2013 |
| Attitudes and managing alcohol problems in general practice: an interaction analysis based on findings from a WHO collaborative study P Anderson, E Kaner, S Wutzke, M Funk, N Heather, M Wensing, R Grol, ... Alcohol and Alcoholism 39 (4), 351-356, 2004 | 178 | 2004 |
| Long-term efficacy, tolerability and safety of nalmefene as-needed in patients with alcohol dependence: A 1-year, randomised controlled study W van den Brink, P Sørensen, L Torup, K Mann, A Gual, ... Journal of Psychopharmacology 28 (8), 733-744, 2014 | 171 | 2014 |
| Alcohol use disorders in primary health care: what do we know and where do we go? J Rehm, P Anderson, J Manthey, KD Shield, P Struzzo, M Wojnar, A Gual Alcohol and alcoholism 51 (4), 422-427, 2016 | 170 | 2016 |
| Why has alcohol consumption declined in countries of southern Europe? A Gual, J Colom Addiction 92, S21-S31, 1997 | 170 | 1997 |
| Alcohol consumption during the COVID‐19 pandemic in Europe: a large‐scale cross‐sectional study in 21 countries C Kilian, J Rehm, P Allebeck, F Braddick, A Gual, M Barták, K Bloomfield, ... Addiction 116 (12), 3369-3380, 2021 | 168 | 2021 |
| A double‐blind, placebo‐controlled study of naltrexone in the treatment of alcohol‐dependence disorder: results from a multicenter clinical trial J Guardia, C Caso, F Arias, A Gual, J Sanahuja, M Ramírez, I Mengual, ... Alcoholism: Clinical and Experimental Research 26 (9), 1381-1387, 2002 | 164 | 2002 |
| Alcohol abstinence in patients surviving an episode of alcoholic hepatitis: prediction and impact on long‐term survival J Altamirano, H López‐Pelayo, J Michelena, PD Jones, L Ortega, P Gines, ... Hepatology 66 (6), 1842-1853, 2017 | 153 | 2017 |
| Alcohol and primary health care: clinical guidelines on identification and brief interventions P Anderson, A Gual, CF Colom Health Department of the Government of Catalonia, 2005 | 141 | 2005 |
| Acamprosate during and after acute alcohol withdrawal: a double-blind placebo-controlled study in Spain A Gual, P Lehert Alcohol and alcoholism 36 (5), 413-418, 2001 | 140 | 2001 |
Jurgen RehmSenior Scientist, Centre for Addiction and Mental HealthVerified email at camh.net
